Literature DB >> 3284479

Captopril in heart failure secondary to a left to right shunt.

N J Shaw1, N Wilson, D F Dickinson.   

Abstract

Captopril was used in 20 infants aged less than 1 year with heart failure secondary to defects with predominantly a left to right shunt that was poorly controlled with digoxin and diuretics. Total daily dose of captopril ranged from 0.88 to 2.5 mg/kg (mean 1.3 mg/kg) in three divided doses. Improvement in the control of heart failure was seen mainly as an increase in the rate of weight gain from a mean of 48 g/week before treatment to 102 g/week on treatment and a decrease in the mean respiratory rate from 68 breaths/minute to 60 breaths/minute. Side effects were seen in four patients--two with asymptomatic mild hypotension, one with renal insufficiency which improved with a reduction in dose, and one with severe oliguria progressing to renal failure. Significant changes in plasma electrolyte concentration did not occur except in the infant who developed acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284479      PMCID: PMC1778804          DOI: 10.1136/adc.63.4.360

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  HYPERSECRETION OF ALDOSTERONE IN DOGS WITH A CHRONIC AORTIC-CAVAL FISTULA AND HIGH OUTPUT HEART FAILURE.

Authors:  J O DAVIS; J URQUHART; J T HIGGINS; E C RUBIN; P M HARTROFT
Journal:  Circ Res       Date:  1964-06       Impact factor: 17.367

2.  Treatment of chronic heart failure: a review of recent drug trials.

Authors:  D P Lipkin; P A Poole-Wilson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

3.  Captopril in heart failure. A double blind controlled trial.

Authors:  J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal:  Br Heart J       Date:  1984-11

4.  Captopril in treatment of infant heart failure: a preliminary report.

Authors:  A M Scammell; R Arnold; J L Wilkinson
Journal:  Int J Cardiol       Date:  1987-09       Impact factor: 4.164

5.  Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.

Authors:  A B Atkinson; J J Morton; J J Brown; D L Davies; R Fraser; P Kelly; B Leckie; A F Lever; J I Robertson
Journal:  Br Heart J       Date:  1980-09

6.  Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease.

Authors:  A R Sinaiko; B L Mirkin; D A Hendrick; T P Green; R F O'Dea
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

  6 in total
  12 in total

1.  Regression of a large congenital hepatic arteriovenous malformation.

Authors:  Hala Mounir Agha; Rania Zakaria; Fatma Alzahraa Mostafa; Hala Hamza
Journal:  Tex Heart Inst J       Date:  2015-04-01

2.  Enalapril in infants with single ventricle: results of a multicenter randomized trial.

Authors:  Daphne T Hsu; Victor Zak; Lynn Mahony; Lynn A Sleeper; Andrew M Atz; Jami C Levine; Piers C Barker; Chitra Ravishankar; Brian W McCrindle; Richard V Williams; Karen Altmann; Nancy S Ghanayem; Renee Margossian; Wendy K Chung; William L Border; Gail D Pearson; Mario P Stylianou; Seema Mital
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

3.  Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle.

Authors:  Seema Mital; Wendy K Chung; Steven D Colan; Lynn A Sleeper; Cedric Manlhiot; Cammon B Arrington; James F Cnota; Eric M Graham; Michael E Mitchell; Elizabeth Goldmuntz; Jennifer S Li; Jami C Levine; Teresa M Lee; Renee Margossian; Daphne T Hsu
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

4.  Enalapril for severe heart failure in infancy.

Authors:  M Frenneaux; R A Stewart; C M Newman; K A Hallidie-Smith
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

5.  Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.

Authors:  Daphne T Hsu; Seema Mital; Chitra Ravishankar; Renee Margossian; Jennifer S Li; Lynn A Sleeper; Richard V Williams; Jami C Levine; Brian W McCrindle; Andrew M Atz; Darlene Servedio; Lynn Mahony
Journal:  Am Heart J       Date:  2009-01       Impact factor: 4.749

Review 6.  ACE inhibitors in pediatric patients with heart failure.

Authors:  Kazuo Momma
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

7.  Enalapril-induced acute renal failure in a newborn infant.

Authors:  Sourabh Dutta; Anil Narang
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

8.  Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts.

Authors:  M W Webster; J M Neutze; A L Calder
Journal:  Pediatr Cardiol       Date:  1992-07       Impact factor: 1.655

9.  Efficacy and dosage of enalapril in congenital and acquired heart disease.

Authors:  A M Leversha; N J Wilson; P M Clarkson; A L Calder; M C Ramage; J M Neutze
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

10.  S-allyl-mercapto-captopril: a novel compound in the treatment of Cohen-Rosenthal diabetic hypertensive rats.

Authors:  Firas Younis; David Mirelman; Aharon Rabinkov; Talma Rosenthal
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.